Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Given Average Rating of “Moderate Buy” by Brokerages
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the sixteen ratings firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average twelve-month price objective […]
More Stories
UAE Halts All Iranian Trade After 2 Missiles Launched From Iranian Territory
By Jill McLaughlin The United Arab Emirates (UAE) halted all trade with Iran after officials determined two missiles detected earlier...
Amazon to Expand Drone Deliveries to Nearly 500 US Cities
By Bill Pan Amazon is expanding its airborne delivery service, with a goal of using drones to deliver small packages...
US Gas Prices on the Rise, Diesel Sees Higher Increase
By Jack Phillips Gas and diesel prices are rising again, according to new data, amid uncertainty over the conflict in...
Trump Says He Brokered ‘Very Good Deal’ With Ottawa, Including Lowered Tariffs on Canada
By Matthew Horwood U.S. President Donald Trump says a preliminary trade deal made with Canada will benefit both countries, including...
How to Generate High-Authority Backlinks? Proven Strategies to Increase Organic Traffic
Creating attractive and useful content is a smart part of SEO. If websites with higher authority and credibility do not...
Health Officials Report More Cases of Flesh-Eating Beach Bacteria
By Jack Phillips Health officials have reported that cases of a rare type of flesh-eating bacteria found in warm seawater...